Mori et al., 2002 - Google Patents
Hyperglycemia-induced alteration of vascular smooth muscle phenotypeMori et al., 2002
- Document ID
- 15577740123049751486
- Author
- Mori S
- Takemoto M
- Yokote K
- Asaumi S
- Saito Y
- Publication year
- Publication venue
- Journal of Diabetes and its Complications
External Links
Snippet
We have previously reported that high glucose stimulates osteopontin (OPN) expression through protein kinase C-dependent pathway, as well as the hexosamine pathway, in cultured rat aortic smooth muscle cells (SMC). The finding prompted us to study in vivo …
- 210000002464 Muscle, Smooth, Vascular 0 title description 2
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mori et al. | Hyperglycemia-induced alteration of vascular smooth muscle phenotype | |
| Saito et al. | Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats | |
| Pritchard et al. | Igs from patients with Graves’ disease induce the expression of T cell chemoattractants in their fibroblasts | |
| Nie et al. | An appropriate loading control for western blot analysis in animal models of myocardial ischemic infarction | |
| Sabri et al. | Protease-Activated Receptor-1–Mediated DNA Synthesis in Cardiac Fibroblast Is via Epidermal Growth Factor Receptor Transactivation: Distinct PAR-1 Signaling Pathways in Cardiac Fibroblasts and Cardiomyocytes | |
| Venkatachalam et al. | Neutralization of interleukin-18 ameliorates ischemia/reperfusion-induced myocardial injury | |
| Hwang et al. | Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair | |
| Pavey et al. | G2 phase cell cycle arrest in human skin following UV irradiation | |
| Bhushan et al. | Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis | |
| Dominguez-Rodriguez et al. | Relation of growth-differentiation factor 15 to left ventricular remodeling in ST-segment elevation myocardial infarction | |
| Park et al. | Effects of advanced glycation end products on differentiation and function of osteoblasts and osteoclasts | |
| Gurjar et al. | Mechanism of inhibition of matrix metalloproteinase-9 induction by NO in vascular smooth muscle cells | |
| Eyries et al. | Modulation of growth factor gene expression in vascular cells by oxidative stress | |
| Burke et al. | Small proline-rich protein 2B drives stress-dependent p53 degradation and fibroblast proliferation in heart failure | |
| Ahmad et al. | Cathepsin-D, adiponectin, TNF-α, IL-6 and hsCRP plasma levels in subjects with diabetic foot and possible correlation with clinical variables: a multicentric study | |
| Christenson et al. | Relation of temporal creatine kinase-MB release and outcome after thrombolytic therapy for acute myocardial infarction | |
| Deardorff et al. | Cytokines and matrix metalloproteinases as potential biomarkers in chronic heart failure | |
| Khodeer et al. | Cardioprotective effect of pioglitazone in diabetic and non-diabetic rats subjected to acute myocardial infarction involves suppression of AGE-RAGE axis and inhibition of apoptosis | |
| TW200835913A (en) | Transient decay amperometry | |
| D'Andrea et al. | Effect of dynamic myocardial dyssynchrony on mitral regurgitation during supine bicycle exercise stress echocardiography in patients with idiopathic dilated cardiomyopathy and ‘narrow’QRS | |
| Averbeck et al. | In situ profiling and quantification of cytokines released during ultraviolet B‐induced inflammation by combining dermal microdialysis and protein microarrays | |
| Basuki et al. | Insulinomimetic Zn complex (Zn (opt) 2) enhances insulin signaling pathway in 3T3-L1 adipocytes | |
| Vukmirović et al. | Predictions and outcomes of atrial fibrillation in the patients with acute myocardial infarction | |
| Konno et al. | Possible hypoglycemic action of SX-fraction targeting insulin signal transduction pathway | |
| Wei et al. | Effects of electrical stimulation on hiPSC-CM responses to classic ion channel blockers |